Product ID:CREST PAINT STRIPPER #29A
MSDS Date:09/02/1997
FSC:8010
NIIN:00-160-5800
Status Code:A
MSDS Number: CKXPL

CREST INDUSTRIAL CHEMICALS INC

6341 BEVERLY HILL
HOUSTON, TX 77242
US

Emergency Phone: 1-800-255-3924

Info Phone: 713-780-1828/8169

Preparer: HENRY SIMMONS

Cage: 77513

CREST INDUSTRIAL CHEMICALS INC

42242 HOUSTON, TX 77057-6500 US

Telephone: 713-780-1828

Cage: 77513

METHYLENE CHLORIDE

CAS: 75-09-2

RTECS: PA8050000

OSHA PEL SEE TABLE Z-2

ACGIH TLV: 174 MG/M3;50 PPM

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

METHANOL

CAS: 67-56-1

RTECS: PC1400000

OSHA PEL 260 MG/M3;200 PPM

ACGIH TLV: 262 MG/M3;200 PPM

EPA Report Quantity: 5000 LBS

DOT Report Quantity: 5000 LBS

Routes of Entry: Inhalation:YES Skin:UNKNOWN Ingestion:YES
Health Hazards Acute and Chronic:EXCESSIVE AMOUNTS MAY CAUSE COLLAPSE
AND DAMAGE TO THE HEART. INHALATION-IN CONFINED OR POORLY
VENTILATED AREAS, VAPORS CAN UNCONSCIOUSNESS. HIGH LEVELS OVER
10000 PPM CAN CAUSE DIZZINESS, DRUNKNESS; CONCENTRATIONS AS LOW AS
10,000 PPM CAN CAUSE UNCONSCIOUSNESS. THESE HIGH LEVELS MAY CAUSE
CARDIAC ARRYTHMIAS. EXCESSIVE EXPOSURE MAY CAUSE IRRITATION TO THE
UPPER RESPIRATORY TRACT.
Explanation of Carcinogenicity:METHYLENE CHLORIDE IS LISTED AS A
POTENTIAL CARCINOGEN BY IARC. METHYLENE CHLORIDE HAS BEEN SHOWN TO
INCREASE THE RATE OF SPONTANEOUSLY OCCURRING MALIGNANT TUMORS IN
THE B6C3F1 MOUSE AND BENIGN TUMORS IN LABORATORY RATS. OTHER
ANIMALS STUDIES, AS WELL AS SEVERAL HUMAN EPIDEMIOLOGY STUDIES,
FAILED TO SHOW A TUMORIGENIC RESPONSE RELATABLE TO METHYLENE
CHLORIDE
Effects of Overexposure:EARLY TO MODERATE CENTRAL NERVOUS SYSTEM
DEPRESSION MAY BE GIDDINESS, HEADACHE, DIZZINESS, AND NAUSEA; IN
EXTREME CASES, UNCONSCIOUSNESS AND DEATH MAY OCCUR.
Medical Cond Aggravated by Exposure:PREEXISTING SKIN, EYE, AND
RESPIRATORY DISORDERS MAY BE AGGRAVATED BY EXPOSURE TO THIS
PRODUCT.

First Aid:EYES CONTACT-IMMEDIATELY FLUSH EYES WITH LARGE AMOUNTS OF
WATER FOR AT LEAST 15 MINUTES. GET MEDICAL ATTENTION IMMEDIATELY.
VAPORS MAY BE IRRITATING TO THE EYES. SKIN CONTACT- IMMEDIATELY
FLUSH WITH W ATER FOR 15 MINUTES. INHALATION-REMOVE VICTIM TO FRESH
AIR AND PROVIDE OXYGEN IF BREATHING IS DIFFICULT. GIVE ARTIFICIAL
RESPIRATION IF NOT BREATHING. GET MEDICAL ATTENTION IMMEDIATELY.
INGESTION-DO N OT INDUCE VOMITING. DO NOT GIVE LIQUIDS TO A DROWSY,
CONVULSING OR UNCONSCIOUSNESS PERSON. GIVE LARGE QUANTITY OF WATER.
IF VOMITING OCCURS, REPEAT LIQUID ADMINISTRATION. GET MEDICAL
ATTENTION IMMEDIA TELY.

Flash Point Method:CC
Flash Point:NONE TO BOILING
Extinguishing Media:CARBON DIOXIDE, CHEMICAL FOAM, OR A WATER MIST
Fire Fighting Procedures:THERMAL DECOMPOSITIONS WILL PRODUCE TOXIC
OXIDES OF CHLORINE AND CARBON. DO NOT ENTER CONFIRMED FIRE SPACE
WITHOUT A FULL BUNKER GEAR (HELMET WITH A FACE SHIELD, BUNKER
COATS, GLOVES, AND RUBBER BOOTS ), INCLUDING A POSITIVE PRESSURE
NIOSH APPROVED SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:OXIDES OF CARBON AND CHLORIDE MAY BE
PRODUCED. BOTH OXIDES ARE DANGEROUS TO HUMANS. CONTAINERS EXPOSED
TO INTENSE HEAT FROM FIRES OR ANY HEAT SOURCE SHOULD BE COOLED WITH
WATER TO PREVENT VAPOR PRESSU RE BUILDUP WHICH COULD RESULT IN
CONTAINER RUPTURE.

Spill Release Procedures:PREVENT ALL BODILY CONTACT WITH SPILLED
MATERIALS. WEAR APPROPRIATE RESPIRATOR AND FULL-BODY PROTECTIVE
CLOTHING. WARNING?AREA OF SPILL MAY BE VERY SLIPPERY. CARE SHOULD
BE TAKEN TO PREVENT FALLING IN TO PRODUCT. SHUT OFF SOURCE OF LEAK
ONLY IF SAFE TO DO SO. DIKE AND CONTAIN SPILL. REMOVE WITH A VACUUM
TRUCK OR PUMP TO STORAGE/SALVAGE VASSALS.

Handling and Storage Precautions:DO NOT STORE IN DIRECT SUNLIGHT. STORE
BELOW 80 DEGREES F. BUT NOT BELOW 32 DEGREES F. AVOID USE IN
UNVENTILATED AREAS. DISCARD BULGING OR DISTORTED CONTAINERS. DO
NOT RECYCLE OR REUSE CONTAINERS. DI SPOSE OF EMPTY CONTAINERS PER
LOCAL, STATE, AND FEDERAL REGULATIONS.
Other Precautions:DO NOT CUT, GRIND, OR WELD ON THIS CONTAINER. EVEN
THOSE CONTAINERS THAT ARE EMPTY WILL RETAIN PRODUCT RESIDUE AND
VAPORS. ALWAYS OBEY HAZARDOUS WARNINGS AND HANDLE EMPTY CONTAINERS
AS IF THEY WERE FU LL.

Respiratory Protection:NIOSH/MSHA APPROVED BREATHING APPARTUS.
Ventilation:LOCAL EXHAUST AND MECHANICAL.
Protective Gloves:SOLVENT RESISTANCE GLOVES THAT HAS BEEN APPROVED FOR
USE WITH THIS PRODUCT.
Eye Protection:FULL FACE SHIELD. DO NOT WEAR CONTACTS AROUND THIS
PRODUCT
Other Protective Equipment:SOLVENT RESISTANCE APRONS, BOOTS, AND SUITS
MUST BE WORN.
Work Hygienic Practices:WASH ALL EXPOSED AREA WITH SOAP AND WATER AFTER
USING THIS PRODUCT. DO NOT SMOKE AROUND THIS PRODUCT.
Supplemental Safety and Health

Melt/Freeze Pt:=46.1C, 115.F
Vapor Pres:360 MM
Vapor Density:>1 AIR =1
Spec Gravity:1.11
VOC Grams/Liter:1.8
Evaporation Rate & Reference:>1 (BUTYL ACETATE =1)
Solubility in Water:SLIGHT
Appearance and Odor:VISCOUS LIQUID WITH SOLVENT ODOR
Percent Volatiles by Volume:96

Stability Indicator/Materials to Avoid:YES
AVOID STRONG OXIDIZERS.
Stability Condition to Avoid:AVOID STRONG OXIDIZERS.
Hazardous Decomposition Products:THERMAL DECOMPOSITION WILL PRODUCE
TOXIC OXIDES OF CARBON AND CHLORINE.

Waste Disposal Methods:DO NOT DISPOSE OF OR DISCHARGE INTO SEWERS OR
NAVIGABLE WATERS. DO NOT ALLOW PRODUCT TO CONTAMINATE GROUND
WATERS. ANY DISPOSAL PRACTICE MUST BE IN COMPLIANCE WITH FEDERAL,
STATE AND LOCAL REGULATIO NS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.